An estimate of global for paziquantel within schistoxomiasis control programmes / Utroska, J. A.

Public ISBD Titre : An estimate of global for paziquantel within schistoxomiasis control programmes Type de document : texte imprimé Auteurs : Utroska, J. A. ; Chen, M. G. ; Dixon, H. Mention d'édition : World Health Organization Editeur : World Health organization Année de publication : [sd] ISBN/ISSN/EAN : CI-07088 Note générale : This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel. Langues : Anglais (eng) Mots-clés : Medicament  Population  Morbidité  Epidemiologie  Politique sanitaire  Recherche Medicale  Programme contrôle  Schistoxomiase  Chimittérapie  Schistosome Index. décimale : 614.4 Incidence des maladies et mesures de prévention : classer ici l'épidémiologie Résumé : This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel. Note de contenu : This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel. An estimate of global for paziquantel within schistoxomiasis control programmes [texte imprimé] / Utroska, J. A. ; Chen, M. G. ; Dixon, H.  . -  World Health Organization . - World Health organization, [sd]. ISSN : CI-07088 This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel. Langues : Anglais (eng) Mots-clés : Medicament  Population  Morbidité  Epidemiologie  Politique sanitaire  Recherche Medicale  Programme contrôle  Schistoxomiase  Chimittérapie  Schistosome Index. décimale : 614.4 Incidence des maladies et mesures de prévention : classer ici l'épidémiologie Résumé : This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel. Note de contenu : This document is a attemp to provide an analytical framework for public health planners and administrators of endemic countries. 1) to reassess estimates of the prevalence of schistoxomiasis, 2) to determine the quantity of proziquantel needed to treat all infected persons with a single dose and, 3) to propose a basis for longitudinal calcultions of praziquantel needs in endemic countries. It emphasizes the limitations of current methodology and available data to calculate both the prevalence of schistoxomiasis and the requisements of a single drug such as praziquantel.

Réservation

Réserver ce document

Exemplaires(1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
CI03B088.200155	CI-07088	Monographie	Bibliothèque CDI-Ouaga	Fond documentaire	Disponible

---

1 (1 - 1 / 1) Par page : 25 50 100 200